HIMS
Hims & Hers Health, Inc.·Healthcare
25.20
5.660%(+1.35)
Close PriceLast Updated: — ET
52W L: $13.7452W H: $70.43
HIMS NEWS
gurufocus.com
17h ago
Hims & Hers Stock Spikes -- Insider Sends Strong Signal With $1 Million Buy
Hims and Hers Health (HIMS) jumped about 5% on Wednesday after director David Wells disclosed a purchase of more than $1 million in company stock, a move that cam
gurufocus.com
17h ago
Hims & Hers Gains 5% on Insider Buying
Hims and Hers Health, Inc. (HIMS) rose 5.07% intraday after director David B. Wells purchased $1.17 million in Class A common stock, acquiring 48,400 shares. Well
zacks.com
18h ago
HIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now?
Hims & Hers and Tempus AI are taking different paths in AI-driven healthcare, but which stock offers stronger upside now? Let's dive in.
benzinga.com
19h ago
Hims & Hers Shares Rally On Million-Dollar Insider Purchase
Shares of Hims & Hers Health Inc (NYSE:HIMS) are trading higher Wednesday morning, fueled by a wave of investor confidence following an insider stock purchase by a key member of the company's leadership team. Here's what investors need to know.
proactiveinvestors.com
1d ago
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA
Hims & Hers Health (NYSE: HIMS) faces a demanding customer acquisition challenge to hit its 2026 revenue guidance amid rising churn risks tied to its oral Wegovy subscription model, Bank of America said. Analysts estimate HIMS would need to add approximately 225,000 new oral Wegovy subscribers per quarter from the second through fourth quarters of 2026 to reach the midpoint of its full-year sales guidance.
proactiveinvestors.com
1d ago
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA
Hims & Hers Health (NYSE: HIMS) faces a demanding customer acquisition challenge to hit its 2026 revenue guidance amid rising churn risks tied to its oral...
